Zhongsheng (John) Yu
About Zhongsheng (John) Yu
Zhongsheng (John) Yu is an Associate Director at Sana Biotechnology, Inc., where he collaborates with bioinformaticians on drug target prioritization and genome profiling. He has a strong background in molecular biology and gene editing technologies, with previous roles at Amgen and Applied StemCell.
Work at Sana Biotechnology
Zhongsheng (John) Yu serves as Associate Director at Sana Biotechnology, Inc. since 2020. In this role, he collaborates with bioinformaticians to prioritize drug targets and conduct genome profiling. His work focuses on advancing disease therapeutics through innovative technology development. Yu's experience in molecular biology and drug discovery enhances the company's research capabilities.
Previous Experience at Amgen
Prior to his current position, Yu worked at Amgen as a Senior Associate Scientist from 2018 to 2020 in South San Francisco. His role involved significant contributions to research and development in the biopharmaceutical sector, leveraging his expertise in molecular biology and drug discovery.
Background in Molecular Biology
Yu has a strong background in molecular biology, having worked at Applied StemCell as a Scientist & Project Manager in 2017. He also served as Group Head of Molecular Biology at the same company for a brief period. His experience includes supervising research associates and lab interns, which contributed to the expansion of molecular biology capacity within the organization.
Education and Expertise
Yu obtained his Ph.D. from the Chinese Academy of Sciences, where he studied Gene Editing Technology and Epigenetics from 2008 to 2013. His academic background laid the foundation for his expertise in CRISPR/Cas9 based cell line engineering, which is essential for high-throughput screening and drug discovery.
Postdoctoral Fellowship at UCSF
Yu completed a postdoctoral fellowship at UCSF from 2014 to 2017. During this time, he conducted research in Genentech Hall, focusing on advanced molecular biology techniques. His experience at UCSF further developed his skills and knowledge in the field, preparing him for subsequent roles in the biotechnology industry.